Literature DB >> 29246371

Editorial overview: Use of PK-PD for antibacterial drug development: decreasing risk and paths forward for resistant pathogens.

Sujata M Bhavnani1, John H Rex2.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 29246371     DOI： 10.1016/j.coph.2017.11.008

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN： 1471-4892            Impact factor:   5.547


× No keyword cloud information.
  2 in total

1.  Pharmacokinetics-Pharmacodynamics of Enmetazobactam Combined with Cefepime in a Neutropenic Murine Thigh Infection Model.

Authors:  Fabian Bernhard; Rajesh Odedra; Sylvie Sordello; Rossella Cardin; Samantha Franzoni; Cédric Charrier; Adam Belley; Peter Warn; Matthias Machacek; Philipp Knechtle
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

Review 2.  The importance of pharmacokinetics and pharmacodynamics in antimicrobial drug development and their influence on the success of agents developed to combat resistant gram negative pathogens: A review.

Authors:  Mary E Palmer; Lauren J Andrews; Taylor C Abbey; Ashley E Dahlquist; Eric Wenzler
Journal:  Front Pharmacol       Date:  2022-07-25       Impact factor: 5.988
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.